What adjustments should be made to a diabetes treatment plan for a patient with consistently elevated blood glucose levels, currently taking 46 units of Humalog (insulin lispro) and 10 units of Lantus (insulin glargine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Regimen Adjustment for Poorly Controlled Type 2 Diabetes

The patient requires a significant increase in basal insulin (Lantus) dose and adjustment of mealtime insulin (Humalog) to achieve better glycemic control.

Current Regimen Assessment

  • The patient is currently on 46 units of Humalog (rapid-acting insulin lispro) and only 10 units of Lantus (long-acting insulin glargine) with persistently elevated blood glucose levels in the 200-300 mg/dL range 1
  • This regimen shows a significant imbalance between basal and bolus insulin components, with inadequate basal insulin coverage 1, 2
  • For most patients with type 2 diabetes, basal insulin requirements are typically higher, often approaching 0.3-0.5 units/kg/day 2

Recommended Insulin Adjustments

Step 1: Increase Basal Insulin (Lantus)

  • Increase Lantus from 10 units to 20-25 units once daily, administered at the same time each evening 1, 2
  • Titrate Lantus by adding 2-4 units every 3-4 days until fasting blood glucose consistently reaches 100-130 mg/dL 1
  • The goal is to establish adequate 24-hour basal insulin coverage to control hepatic glucose production between meals and during sleep 1, 2

Step 2: Optimize Mealtime Insulin (Humalog)

  • Distribute the 46 units of Humalog across three meals based on carbohydrate content of each meal 1
  • Typical distribution: 30-40% breakfast, 30-40% lunch, 30-40% dinner (adjust based on meal patterns) 1
  • Consider using an insulin-to-carbohydrate ratio for more precise dosing if the patient can count carbohydrates 1

Step 3: Implement Correction Factor

  • Add a correction factor of 1 unit of Humalog for every 50 mg/dL above target pre-meal glucose 1
  • Pre-meal targets should be <140 mg/dL and random glucose <180 mg/dL 1, 3

Monitoring and Further Adjustments

  • Monitor blood glucose before meals and at bedtime daily during adjustment period 1
  • Assess for patterns of hyperglycemia or hypoglycemia to guide further adjustments 2
  • If fasting glucose is at target but post-meal glucose remains elevated, focus on increasing mealtime insulin 1
  • If post-meal glucose is controlled but fasting glucose remains elevated, continue increasing basal insulin 1

Important Considerations

  • The total daily insulin requirement for patients with type 2 diabetes is often around 1 unit/kg/day, with approximately 50% as basal insulin 2, 4
  • The current regimen has an inappropriate ratio with only 18% as basal insulin (10 units Lantus out of 56 total units) 1
  • Hypoglycemia risk increases with insulin adjustment - educate patient on recognition and treatment of hypoglycemia 5
  • Consider adding or optimizing oral agents such as metformin if not contraindicated 1

When to Consider Further Treatment Modifications

  • If blood glucose remains poorly controlled despite optimized basal-bolus insulin therapy (total daily dose >0.5 units/kg), consider:
    • Adding a GLP-1 receptor agonist to improve postprandial control and potentially reduce insulin requirements 1
    • Switching to premixed insulin formulations (e.g., 70/30 or 75/25) if adherence to multiple daily injections is an issue 1, 6
    • Referral to an endocrinologist for consideration of insulin pump therapy in appropriate candidates 1

Pitfalls to Avoid

  • Relying solely on sliding-scale insulin adjustments without addressing inadequate basal insulin 1, 3
  • Failing to adjust mealtime insulin when basal insulin is increased 2
  • Neglecting to educate the patient on proper insulin administration technique and timing 4
  • Not considering other factors affecting glucose control such as diet, physical activity, stress, or concurrent medications 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Glargine Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Reexamining the evidence for inpatient glucose control: new recommendations for glycemic targets.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010

Research

Hypoglycemia in diabetes.

Diabetes care, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.